表紙
市場調查報告書

DNA定序的全球市場

DNA Sequencing

出版商 Global Industry Analysts, Inc. 商品編碼 913112
出版日期 內容資訊 英文 192 Pages
商品交期: 最快1-2個工作天內
價格
DNA定序的全球市場 DNA Sequencing
出版日期: 2020年09月01日內容資訊: 英文 192 Pages
簡介

本報告提供全球DNA定序市場調查,提供市場概要,各用途(診斷,藥物研發,生物標記開發,個人化醫療,農業·動物研究,其他),終端用戶(研究中心·學術機構·政府機關,生物科技企業,製藥企業,醫院·診療所,其他),各地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭情形

  • F. HOFFMANN-LA ROCHE AG
  • ILLUMINA
  • PACIFIC BIOSCIENCES OF CALIFORNIA
  • THERMO FISHER SCIENTIFIC

第5章 調查資料

目錄
Product Code: MCP11607

Global DNA Sequencing Market to Reach $28.8 Billion by 2027

Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Diagnostics, one of the segments analyzed in the report, is projected to record a 17.7% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery segment is readjusted to a revised 15.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 16.6% CAGR

The DNA Sequencing market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5 Billion by the year 2027 trailing a CAGR of 16.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.5% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Biomarker Discovery Segment to Record 18.1% CAGR

In the global Biomarker Discovery segment, USA, Canada, Japan, China and Europe will drive the 17.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.5 Billion in the year 2020 will reach a projected size of US$7.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 192-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Pacific Biosciences of California, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • DNA Sequencing Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 2: World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 3: World 15-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 5: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 6: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 8: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 11: World Historic Review for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Biomarker Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 14: World Historic Review for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Agriculture & Animal Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 17: World Historic Review for Agriculture & Animal Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 18: World 15-Year Perspective for Agriculture & Animal Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Research Centers and Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 23: World Historic Review for Research Centers and Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 24: World 15-Year Perspective for Research Centers and Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 26: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 27: World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 29: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 30: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 32: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 33: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 35: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 36: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US DNA Sequencing Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 37: USA Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 38: USA Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 39: USA 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 41: USA Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 42: USA 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 44: Canada Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 45: Canada 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 47: Canada Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 48: Canada 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 50: Japan Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 51: Japan 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 53: Japan Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 54: Japan 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 55: China Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 56: China Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 57: China 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 59: China Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 60: China 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European DNA Sequencing Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 61: Europe Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 62: Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 63: Europe 15-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 64: Europe Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 65: Europe Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 66: Europe 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 68: Europe Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 69: Europe 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 70: France Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 71: France Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 72: France 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 73: France Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 74: France Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 75: France 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 76: Germany Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 77: Germany Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 78: Germany 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 79: Germany Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 80: Germany Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 81: Germany 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 82: Italy Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 83: Italy Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 84: Italy 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 85: Italy Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 86: Italy Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 87: Italy 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 88: UK Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 89: UK Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 90: UK 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 91: UK Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 92: UK Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 93: UK 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 94: Rest of Europe Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 95: Rest of Europe Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 96: Rest of Europe 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of Europe Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 98: Rest of Europe Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 99: Rest of Europe 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 100: Asia-Pacific Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 101: Asia-Pacific Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 102: Asia-Pacific 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 104: Asia-Pacific Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 105: Asia-Pacific 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 106: Rest of World Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 107: Rest of World Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 108: Rest of World 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 109: Rest of World Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 110: Rest of World Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 111: Rest of World 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42